Advisory Alpha, LLC Aurinia Pharmaceuticals Inc. Transaction History

Advisory Alpha, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $25,880 - $32,100	-2,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $26,380 - $33,320	2,000 New	2,000 $31,000
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $28,240 - $36,660	-2,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$5.34 - $6.59 $10,680 - $13,180	2,000 New	2,000 $10,000
Q2 2019 Aug 16, 2019	SELL	$6.05 - $6.75 $12,100 - $13,500	-2,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$6.06 - $7.64 $12,120 - $15,280	2,000 New	2,000 $0

227

58.9M

949K

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.19B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.